[go: up one dir, main page]

KR20020082301A - The new manganese-chiral compounds and thereof use - Google Patents

The new manganese-chiral compounds and thereof use Download PDF

Info

Publication number
KR20020082301A
KR20020082301A KR1020010021504A KR20010021504A KR20020082301A KR 20020082301 A KR20020082301 A KR 20020082301A KR 1020010021504 A KR1020010021504 A KR 1020010021504A KR 20010021504 A KR20010021504 A KR 20010021504A KR 20020082301 A KR20020082301 A KR 20020082301A
Authority
KR
South Korea
Prior art keywords
compound
mmol
catalyst
phenyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1020010021504A
Other languages
Korean (ko)
Other versions
KR100681326B1 (en
Inventor
안광현
유경아
최선호
문치장
Original Assignee
주식회사 중외제약
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 중외제약 filed Critical 주식회사 중외제약
Priority to KR1020010021504A priority Critical patent/KR100681326B1/en
Publication of KR20020082301A publication Critical patent/KR20020082301A/en
Application granted granted Critical
Publication of KR100681326B1 publication Critical patent/KR100681326B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE: Provided are a novel manganese-chiral compound and its use as a catalyst in the enantioselective epoxidation of olefin to produce a compound having high stereoselectivity. CONSTITUTION: The novel manganese-chiral compound is represented by formula(1), wherein R1 is phenyl or 6 member ring when two R1 groups are combined together; R2 and R3 are C1-C10 alkyl; R4 is C1-C10 alkyl or phenyl; and X is halogen. An asymmetric epoxide compound is produced by asymmetrical oxidation of olefin compound using the compound of formula(1) as a catalyst, wherein R5 is phenyl or substituted phenyl; R6 is hydrogen, C1 to C3 alkyl or -COOR7, or can form ring compounds together with R5 and R6; R7 is C1 to C10 alkyl or phenyl; Y is hydrogen, -CN or -COOR7; and an oxidizing agent is LiOCl.

Description

신규한 망간-키랄성 화합물 및 그의 이용방법{THE NEW MANGANESE-CHIRAL COMPOUNDS AND THEREOF USE}Novel manganese-chiral compounds and methods of use thereof {THE NEW MANGANESE-CHIRAL COMPOUNDS AND THEREOF USE}

본 발명은 신규한 망간-키랄성 화합물 및 그 제조방법에 관한 것이다. 더욱 구체적으로는, 상기 신규한 망간-키랄성 화합물은 하기 화학식 1 로 표시되며, 하기 화학식 2 로 표시되는 올레핀의 입체선택성 에폭시화반응 (enantioselective epoxidation) 의 촉매로 사용될 수 있다.The present invention relates to novel manganese-chiral compounds and methods for their preparation. More specifically, the novel manganese-chiral compound is represented by the following formula (1), can be used as a catalyst for the stereoselective epoxidation (enantioselective epoxidation) of the olefin represented by the following formula (2).

[화학식 1][Formula 1]

[식 중, R1은 페닐기이거나, 둘이 서로 연결되어 6 환 고리임을 나타내고,[Wherein, R 1 is a phenyl group, or two are connected to each other to represent a 6-ring ring,

R2, R3는 탄소수 1∼10 의 알킬기를 나타내고,R <2> , R <3> represents a C1-C10 alkyl group,

R4는 C1∼C10의 알킬기 또는 페닐기를 나타내며,R 4 represents a C 1 to C 10 alkyl group or a phenyl group,

X 는 할로겐을 나타냄]X represents halogen]

[식 중, R5는 페닐 또는 치환된 페닐기이고,[Wherein R 5 is a phenyl or substituted phenyl group,

R6는 수소, C1~ C10알킬 또는 -COOR7(R7은 C1∼C10알킬 또는 페닐)을 나타내고,R 6 represents hydrogen, C 1 -C 10 alkyl or -COOR 7 (R 7 is C 1 -C 10 alkyl or phenyl),

또한, R5와 R6는 페닐과 함께 고리를 형성하여In addition, R 5 and R 6 together with phenyl form a ring

와 같은 구조를 가짐을 나타내며, Has the same structure as

Y 는 수소, -CN,또는-COOR7을 나타냄]Y represents hydrogen, -CN, or -COOR 7 ]

입체 선택적 에폭시화반응(enantioselective epoxidation) 즉, 비대칭 산화반응은 최근 20 년간 많은 유기화학자들에 의해 연구되어왔다. 1980 년대 Groves 와 Meyers 가 처음으로 키랄성 금속포르피린(chiral metalloporphyrin)을 촉매로 이용하여 입체선택성 에폭시화 반응을 수행한 후, 많은 광학 활성을 갖는 철 또는 망간 포르피린이 개발되어 작용기가 없는 올레핀(unfunctionalized olefin)의 일종인 스티렌의 비대칭 에폭시화 반응에 촉매로 사용되었다. 그러나, 원하는 입체선택성을 갖는 에폭시 화합물의 광학순도(ee %)는 50 % 이하라고 보고되었으며, 나아가, 이러한 포르피린 촉매는 합성이 어렵고 그 수득률이 좋지 않은 문제점이 있다.Enantioselective epoxidation, or asymmetric oxidation, has been studied by many organic chemists in recent 20 years. In the 1980s, Groves and Meyers first performed stereoselective epoxidation reactions using chiral metalloporphyrins as catalysts, followed by the development of iron or manganese porphyrins with many optical activities, resulting in unfunctionalized olefins. It was used as a catalyst for the asymmetric epoxidation of styrene, However, the optical purity (ee%) of the epoxy compound having the desired stereoselectivity has been reported to be 50% or less, and furthermore, such porphyrin catalysts are difficult to synthesize and have poor yields.

현재까지 비대칭 촉매반응 중 가장 좋은 결과 및 산업화의 가능성을 제시한 반응은 K.B. Sharpless의 비대칭 산화반응으로, 타이타늄(IV) 알콕사이드 및 광학활성을 갖는 타르타르 에스테르(tartaric ester) 존재하에서 t-부틸하이드로퍼옥사이드 (t-butyl hydroperoxide)와 알릴성 알콜(allylic alcohol)을 반응시켜 높은 입체선택성을 나타내는 것으로 보고되었다. 그러나, 이 방법은 알릴 작용기를 갖는 특정 올레핀에만 제한적으로 사용된다.To date, the best results of asymmetric catalysis and the possibility of industrialization are K.B. Sharpless asymmetric oxidation, high steric reaction by reacting t-butyl hydroperoxide and allyl alcohol in the presence of titanium (IV) alkoxide and optically active tartaric ester. It has been reported to indicate selectivity. However, this method is of limited use only for certain olefins having allyl functionality.

이러한 단점들을 고려하여, Jacobsen 은 망간 살렌 배위화합물(manganese salen complex)이라는 촉매를 개발하였으며, 좋은 입체선택성 결과(80~99 % ee)를 보여주었다. 여기서, "ee" 라는 표기는 광학 순도(enantiomeric excess)의 약칭이다. 나아가, 1992 년 출원된 특허(공개번호 WO 93/03838)에는 다양한 종류의 촉매와 의약품에 유용하게 활용되는 중간체의 합성법이 언급되어 있다.In view of these shortcomings, Jacobsen developed a catalyst called manganese salen complex and showed good stereoselectivity results (80-99% ee). Here, the notation "ee" is an abbreviation of optical purity (enantiomeric excess). Furthermore, the patent filed in 1992 (Publication No. WO 93/03838) mentions a method for the synthesis of intermediates useful for various types of catalysts and pharmaceuticals.

한편, Jacobsen 과 더불어 망간 살렌 배위화합물을 촉매로 이용하여 좋은 결과를 보고하고 있는 Katsuki 의 연구를 살펴보면, 촉매의 구조적인 면에서는 Jacobsen 과 같이 키랄성 아민을 도입하여 에폭사이드의 키랄성(chirality)을 결정할 수 있도록 하였고, 이에 한단계 더 나아가 키랄기로 아릴기를 추가함으로서 상당히 좋은 광학순도(83∼99 % ee)를 얻을 수 있게 하였다. 그러나, Katsuki 촉매의 합성과정은 상당히 비싼 시약의 사용과 까다로운 반응조건 등이 단점으로 지적되고 있다.On the other hand, Katsuki's research, which reports good results using manganese salen coordination compounds as a catalyst, shows that the chirality of epoxides can be determined by introducing chiral amines like Jacobsen. In addition, by adding an aryl group to the chiral group, a very good optical purity (83-99% ee) can be obtained. However, the synthesis of Katsuki catalyst has been pointed out by the use of quite expensive reagents and difficult reaction conditions.

이러한 문제점을 개선하고자, 본 발명자들은 종래의 망간 살렌 배위화합물 촉매의 특성을 이용하면서 비대칭 산화반응의 입체선택성을 향상시킬 수 있으며 그 제조방법이 용이한 새로운 망간 살렌 배위화합물을 구상하게 되었다.In order to improve this problem, the present inventors have envisioned a new manganese salen coordination compound that can improve the stereoselectivity of the asymmetric oxidation reaction while using the properties of the conventional manganese salen coordination compound catalyst.

이 새로운 망간 살렌 화합물 (Ⅰ)은 페놀의 파라위치에 전자공여성 (electron-donating) 기인 알콕기와 각각 입체적인 영향을 줄 수 있는 두 개의 알킬기 또는 방향족을 도입하여 입체선택적 에폭시화(enantioselective epoxidation) 반응시 선택성을 높일 수 있게 하였다. 이러한 결과를 바탕으로, 다양한 올레핀과 반응하여 입체선택적 에폭시 화합물들을 제조함으로써 본 발명을 완성하게 되었다.This new manganese salen compound (Ⅰ) introduces an alkoxy group, an electron-donating alkoxy group, and two alkyl groups or aromatics, each of which can have a steric effect, at the para-position of phenol, thereby providing a selective selectivity during the enantioselective epoxidation reaction. To increase. Based on these results, the present invention was completed by preparing stereoselective epoxy compounds by reacting with various olefins.

본 발명은 신규한 망간-키랄성 화합물 및 그 이용방법을 제공한다. 더욱 구체적으로는, 화학식 1 로 표시되는 신규한 화합물 및 상기 화합물을 촉매로 이용하여 화학식 2 로 표시되는 올레핀 화합물을 비대칭 산화반응시킴으로서 대응하는 에폭시화합물(epoxide)을 얻는 방법을 제공한다.The present invention provides novel manganese-chiral compounds and methods of using the same. More specifically, there is provided a novel compound represented by the formula (1) and a method for obtaining a corresponding epoxy compound by asymmetric oxidation of the olefin compound represented by the formula (2) by using the compound as a catalyst.

[화학식 1][Formula 1]

[식 중, R1은 페닐기이거나, 둘이 서로 연결되어 6 환 고리임을 나타내고,[Wherein, R 1 is a phenyl group, or two are connected to each other to represent a 6-ring ring,

R2, R3는 탄소수 1∼10 의 알킬기를 나타내고,R <2> , R <3> represents a C1-C10 alkyl group,

R4는 C1∼C10의 알킬기 또는 페닐기를 나타내며,R 4 represents a C 1 to C 10 alkyl group or a phenyl group,

X 는 할로겐 나타냄]X represents halogen]

[화학식 2][Formula 2]

[식 중, R5는 페닐 또는 치환된 페닐기이고,[Wherein R 5 is a phenyl or substituted phenyl group,

R6는 수소, C1~ C10알킬 또는 -COOR7(R7은 C1∼C10알킬 또는 페닐) 을 나타내고,R 6 represents hydrogen, C 1 -C 10 alkyl or -COOR 7 (R 7 is C 1 -C 10 alkyl or phenyl),

그리고, R5와 R6는 페닐과 함께 고리를 형성하여And R 5 and R 6 form a ring together with phenyl

와 같은 구조를 가짐을 나타내며, Has the same structure as

Y 는 수소, -CN,또는-COOR7을 나타냄]Y represents hydrogen, -CN, or -COOR 7 ]

본 발명에 따른 화학식 1 로 표시되는 화합물의 제조방법은 다음과 같다.The preparation method of the compound represented by Formula 1 according to the present invention is as follows.

출발물질로 5-methoxysalicylic acid 를 사용하였고, 아세톤 용매하에 탄산칼륨, 디메틸술파이드 (Me2S) 를 실온에서 반응하여 메칠에스테르를 만든후, 마그네슘과 브로모벤젠으로 만들어진 그리냐르 (Grignard) 시약을 가하여 다이올을 합성하는데, 이때 사용되어지는 그리냐르 시약의 양은 에스테르에 대하여 1∼100 배 당량, 바람직하게는 5∼50 배 당량, 더욱 바람직하게는 2∼5 배 당량으로 사용한다. 만들어진 다이올은 페놀 위치에만 선택적으로 보호하기 위해 메톡시메톡시클로라이드 (이하, MOMCl 라고 함) 반응을 수소화나트륨 (NaI) 를 사용하였고, 남아있는 2°알코올은 수소화나트륨, 요오드메탄 (요오드메탄) 를 용매하에서 반응하여 메톡시 화합물을 생성하였다. 이 메톡시 화합물은 디메칠포름아미드를 수소화나트륨 하에서 반응하면, 오르토 위치에 알데히드를 도입할수 있다. 여기에 묽은 염산과 메탄올을 가하면 보호기가 제거된 알데히드가 얻어진다. 이렇게 합성된 알데히드는 키랄 아민인 (1R,2R)-(+)-1,2-diphenylethylenediamine 을 무수 에탄올에 녹인후 2시간동안 환류반응하여 키랄 리간드를 합성하고 망간(Ⅱ)아세테이트를 넣어 환류반응한후, 리튬 클로라이드 (LiCl) 를 첨가하여 갈색의 새로운 촉매를 총 8 단계에 걸쳐 85 % 이상으로 합성하였다.5-methoxysalicylic acid was used as a starting material. Methyl ester was prepared by reacting potassium carbonate and dimethyl sulfide (Me 2 S) in acetone solvent at room temperature, and then Grignard reagent made of magnesium and bromobenzene was prepared. To synthesize the diol, the amount of Grignard reagent used is 1 to 100 equivalents, preferably 5 to 50 equivalents, more preferably 2 to 5 equivalents, based on the ester. The resulting diols used sodium hydride (NaI) for the methoxymethoxychloride (hereinafter referred to as MOMCl) reaction to selectively protect only the phenol position, and the remaining 2 ° alcohols were sodium hydride, iomethane (iomethane) Was reacted in a solvent to produce a methoxy compound. This methoxy compound can introduce an aldehyde at the ortho position by reacting dimethylformamide under sodium hydride. Dilute hydrochloric acid and methanol are added to the aldehyde from which the protecting group is removed. The aldehyde thus synthesized was dissolved chiral amine (1R, 2R)-(+)-1,2-diphenylethylenediamine in anhydrous ethanol and refluxed for 2 hours to synthesize chiral ligand and reflux with manganese (II) acetate. Afterwards, lithium chloride (LiCl) was added to synthesize a brown fresh catalyst at least 85% over a total of eight steps.

이하에 본 발명을 더욱 상세하게 설명한다.The present invention will be described in more detail below.

본 발명자들은 새로운 개발된 화학식 1 의 화합물을 촉매로 이용하여 비대칭 에폭시화 반응의 실시하여 화합물 (Ⅲ) 의 키랄 에폭사이드 화합물을 얻었다The present inventors conducted asymmetric epoxidation reaction using a newly developed compound of formula 1 as a catalyst to obtain a chiral epoxide compound of compound (III).

반응식 2 를 구체적으로 설명하면 다음과 같다. 출발물질로 화합물 (Ⅱ)의 올레핀과 망간-살렌 촉매, 첨가제 4-페닐피리딘-N-옥시드(4-PPNO) 을 넣고 용매의 존재하에 증류수에녹인후 pH 를 염기상태로 맞춘후 2∼5 시간 반응하여 키랄 에폭사이드(Ⅲ) 를 제조한다.The reaction scheme 2 is described in detail as follows. As a starting material, an olefin of compound (II), a manganese-salen catalyst, and additive 4-phenylpyridine-N-oxide (4-PPNO) were added thereto, dissolved in distilled water in the presence of a solvent, and then the pH was adjusted to 2-5. Reaction with time produces chiral epoxide (III).

본 발명에 있어서 촉매인 화합물 (Ⅰ)은 반응물인 화합물 (Ⅱ)에 대하여 1∼100 mol% 당량, 바람직하게는 1∼50 mol% 당량, 더욱 바람직하게는 1∼10 mol% 당량으로 사용한다. 첨가제는 특별히 한정되지는 않으나, 일반적으로 10∼50 mol% 당량을 사용한다. 산화제인 LiOCl 은 기존의 다른 산화제보다 훨씬 좋은 결과를 나타내어 주며, 일반적으로 1∼5 mol% 당량을 사용한다. 또한 반응온도는 - 78 ℃ ∼ 50 ℃에서 진행하였으며, 용매의 존재 또는 부재하에서 수행하였다. 이때 용매의 존재하에 반응을 수행할 경우 디클로로메탄이 가장 바람직하다.In the present invention, compound (I) as a catalyst is used in an amount of 1 to 100 mol% equivalent, preferably 1 to 50 mol% equivalent, more preferably 1 to 10 mol% equivalent to compound (II) as a reactant. The additive is not particularly limited, but generally 10 to 50 mol% equivalent is used. LiOCl, an oxidant, has much better results than other oxidants, and generally uses 1 to 5 mol% equivalents. In addition, the reaction temperature was carried out at -78 ℃ to 50 ℃, was carried out in the presence or absence of a solvent. In this case, dichloromethane is most preferred when the reaction is carried out in the presence of a solvent.

본 발명에 따른 올레핀의 비대칭 에폭시화 반응 결과는 상당히 높은 입체선택성을 보여 주는데, cis-β-메틸스티렌의 경우 100 % 의 수율과 99 % ee의 결과를 보여 주었다. 이 결과는 이미 보고되어져 있는 어떤 결과보다도 좋은 결과이다. 특히 산화제로 LiOCl 을 사용할 경우 기존에 알려진 경제적인 산화제로 이용된 NaOCl에 비해 그 반응속도가 매우 빨라지고 수율또한 2 배 이상 향상되었다. NaOCl 경우 인산염 완충 (phosphate buffer) 용액으로 pH 를 조절하였으나, LiOCl 의 경우 단지 물에 녹여 pH 를 조절할수 있으므로 반응과정이 기존의 반응에 비해 훨씬 간편함을 알수 있다.The results of the asymmetric epoxidation of the olefins according to the present invention show a considerably high stereoselectivity, with 100% yield and 99% ee for cis-β-methylstyrene. This result is better than any previously reported result. In particular, when LiOCl is used as an oxidant, the reaction rate is much faster and the yield is more than doubled compared to NaOCl, which is a known economical oxidant. In the case of NaOCl, the pH was adjusted with a phosphate buffer solution. However, in the case of LiOCl, the pH was adjusted by only dissolving in water.

[실시예]EXAMPLE

이하, 실시예를 들어 본 발명을 상세히 설명하지만, 본 발명은 하기 실시예로만 한정되는 것은 아니다.Hereinafter, although an Example is given and this invention is demonstrated in detail, this invention is not limited only to a following example.

하기 실시예들에서는 다음과 같은 사항을 공통으로 하고 있다.In the following examples, the following are common.

합성한 화합물을 확인하기 위한 핵자기 공명 분광법(NMR spectrometer)은 Hitachi R1100 60 MHz CW-NMR, Brucker DPX300 300 MHz FT-NMR, Jeol JMR-LA300 300 MHz FT-NMR, Jasco FT/IR-4300, Varian 3300 GC 를 사용하였다.Nuclear magnetic resonance spectroscopy (NMR spectrometer) to identify the synthesized compounds are Hitachi R1100 60 MHz CW-NMR, Brucker DPX300 300 MHz FT-NMR, Jeol JMR-LA300 300 MHz FT-NMR, Jasco FT / IR-4300, Varian 3300 GC was used.

NMR 에서 화학적 이동(chemical shift)은 내부표준물질인 TMS(Tetramethyl silane)를 기준으로 δ-단위(unit)로 표시하였고 "화학적 이동 (적분세기 : integrated intensity, 중복도 : multiplicity, 커플링 상수 : coupling constant (Hz))" 로 표시하였다.The chemical shift in NMR is expressed in δ-units based on the internal standard TMS (Tetramethyl silane) and "chemical shift (integrated intensity, integrated intensity, multiplicity, coupling constant: coupling). constant (Hz)) ".

GC 는 supelco β- Dex 325 컬럼과 운반기체로 질소를 사용하였고, 주입시 압력은 7 psi 로 고정시켰고 온도 프로그램은 90 ℃에서 5 분간 유지하였고 1 ℃/분 의 속도로 120 ℃까지 승온시킨 후 120 ℃에서 10 분간 지속시켰다.GC used nitrogen as a supelco β-Dex 325 column and carrier gas, the pressure was fixed at 7 psi during injection, the temperature program was maintained at 90 ° C for 5 minutes, and the temperature was raised to 120 ° C at a rate of 1 ° C / min and then 120 It was continued for 10 minutes at ℃.

사용한 시약은 Aldrich 사, Sigma 사, Lancaster 사, Acros 사, 그리고 Merk 사 제품을 사용하였다. 반응 용매인 테트라하이드로푸란(테트라하이드로푸란)와 염화메틸렌 (methylene chloride)은, 삼전화학 제품을 질소 분위기 하에서 나트륨 또는 칼슘하이드라이드(CaH2)로 수분을 제거하고 증류하여 사용하였다. TLC(Thin Layer Chromatography) 는 Merk Kiesegel 60F∼254를 사용하였고, TLC 후 확인은 UV-램프와 PMA, 바닐린(vanilin) 발색시약을 이용하였으며, 플래쉬 칼럼 크로마토그래피(flash column chromatography)는 230∼400 메쉬 실리카겔을 사용하였다.Reagents used were Aldrich, Sigma, Lancaster, Acros, and Merk. Tetrahydrofuran (tetrahydrofuran) and methylene chloride, which are reaction solvents, were used by distilling the trielectric chemical product with sodium or calcium hydride (CaH 2 ) under nitrogen atmosphere. TLC (Thin Layer Chromatography) was used Merk Kiesegel 60F ~ 254, and after TLC, UV-lamp, PMA, vanilin coloring reagent was used, flash column chromatography (230) to 400 mesh Silica gel was used.

[실시예 1] 메틸 2-히드록시-5-메톡시벤조에이트의 합성Example 1 Synthesis of Methyl 2-hydroxy-5-methoxybenzoate

질소분위기하에서 50 mL 투-넥 (two-neck) 플라스크에 5-메톡시살리실산(1 g, 5.95 mmol)을 무수 아세톤(10 mL)에 용해시킨 후, 탄산칼륨(830 mg, 6.54 mmol)을 넣고 1 시간 가량 상온에서 교반하였다. 그 후, 디메틸 술페이트(680 ㎕, 6.54 mmol)를 가하여 1 시간 동안 반응시켰다. 물을 가하여 반응을 종결 시킨 후 염화메틸렌을 넣어 생성물을 추출하고 무수 황산마그네슘으로 물을 제거시킨 후, 여과하여 얻은 염화메틸렌 용액을 감압하에서 농축시켜 노란색 액체인 메칠에스테르화합물 1 (1.07 g, 수득율=100 %)을 얻었다.Under a nitrogen atmosphere, 5-methoxysalicylic acid (1 g, 5.95 mmol) was dissolved in anhydrous acetone (10 mL) in a 50 mL two-neck flask, followed by adding potassium carbonate (830 mg, 6.54 mmol). Stirred at room temperature for about 1 hour. Thereafter, dimethyl sulfate (680 µl, 6.54 mmol) was added thereto and reacted for 1 hour. After completion of the reaction by adding water, methylene chloride was added to extract the product. The water was removed with anhydrous magnesium sulfate, and the methylene chloride solution obtained by filtration was concentrated under reduced pressure to give a yellow liquid of methyl ester compound 1 (1.07 g, yield = 100%).

Rf 값 : 0.58 (EA : Hex = 1 : 3)Rf value: 0.58 (EA: Hex = 1: 3)

1H-NMR (CDCl3,200 MHz) : δ10.38(s, 1H), 7.28(d, 1H), 7.06(dd, 1H), 6.91(d, 1H), 3.93(s, 3H), 3.78(s, 3H) 1 H-NMR (CDCl 3, 200 MHz): δ 10.38 (s, 1H), 7.28 (d, 1H), 7.06 (dd, 1H), 6.91 (d, 1H), 3.93 (s, 3H), 3.78 (s, 3H)

EA : calcd. for C9H10O4(182.18) C=59.34, H=5.53; found C=61.03, H=5.61EA: calcd. for C 9 H 10 O 4 (182.18) C = 59.34, H = 5.53; found C = 61.03, H = 5.61

[실시예 2] 2-[히드록시(디페닐)메틸]-4-메톡시페놀의 합성Example 2 Synthesis of 2- [hydroxy (diphenyl) methyl] -4-methoxyphenol

질소분위기하에서 50 mL 투-넥 둥근 플라스크에 마그네슘(648 mg, 26.68 mmol)을 넣고 토치를 이용하여 건조시킨후, 테트라하이드로푸란(10 mL)와 브로모벤젠(2.81 mL, 26.68 mmol)을 가하여 1 시간 동안 반응시켜 페닐마그네슘브로마이드 (페닐마그네슘브로마이드) 를 만들었다.Magnesium (648 mg, 26.68 mmol) was added to a 50 mL two-neck round flask under nitrogen atmosphere, and dried using a torch. Then, tetrahydrofuran (10 mL) and bromobenzene (2.81 mL, 26.68 mmol) were added thereto. Reaction was performed for a period of time to form phenylmagnesium bromide (phenylmagnesium bromide).

질소분위기하에서 50 mL 투-넥 둥근 플라스크에 화합물 1(1.07 g, 5.9 mmol)을 무수 테트라하이드로푸란(5 mL)에 녹인후 위에서 만든 페닐마그네슘브로마이드 용액을 서서히 넣고 1 시간 동안 상온에서 교반하였다. 1 N 염산을 넣어 반응종결 후 염화메틸렌으로 추출하고 무수 황산마그네슘으로 물을 제거시킨 후, 여과하여 얻은 염화메틸렌 용액을 감압하에서 농축시키고, 에틸아세테이트와 헥산으로 재결정하여 흰색 고체 인 다이올화합물 2 (1.8 g, 수득율≒100 %)를 얻었다.Compound 1 (1.07 g, 5.9 mmol) was dissolved in anhydrous tetrahydrofuran (5 mL) in a 50 mL two-neck round flask under a nitrogen atmosphere, and the phenylmagnesium bromide solution prepared above was slowly added thereto, and stirred at room temperature for 1 hour. After completion of the reaction by adding 1 N hydrochloric acid, extraction was performed with methylene chloride, water was removed with anhydrous magnesium sulfate, and the methylene chloride solution obtained by filtration was concentrated under reduced pressure, and recrystallized with ethyl acetate and hexane to obtain a white solid diol compound 2 ( 1.8 g, yield # 100%) were obtained.

Rf 값 : 0.41 (EA : Hex= 1 : 3)Rf value: 0.41 (EA: Hex = 1: 3)

1H-NMR(CDCl3,400 MHz) : δ7.57(s, 1H), 7.33(m, 6H), 7.23(m, 4H), 1 H-NMR (CDCl 3, 400 MHz): δ 7.57 (s, 1H), 7.33 (m, 6H), 7.23 (m, 4H),

6.83(d,J=8.8Hz, 1H), 6.77(dd,J A=8.7Hz,6.83 (d, J = 8.8 Hz, 1H), 6.77 (dd, J A = 8.7 Hz,

J B=2.9Hz, 1H), 6.12(d,J=2.9Hz, 1H), 3.76(s, 1H), J B = 2.9 Hz, 1H), 6.12 (d, J = 2.9 Hz, 1H), 3.76 (s, 1H),

3.61(s, 3H)3.61 (s, 3 H)

IR(KBr) : 3304, 3061, 1490, 1446, 1008, 754cm-1 IR (KBr): 3304, 3061, 1490, 1446, 1008, 754 cm -1

mp : 154-159 ℃mp: 154-159 ° C.

[실시예 3] 3-[히드록시(디페닐)메틸]-4-(메톡시메톡시)아니솔의 합성Example 3 Synthesis of 3- [hydroxy (diphenyl) methyl] -4- (methoxymethoxy) anisole

질소분위기하에서 50 mL 투-넥 둥근 플라스크에 다이올 화합물 2(1 g, 3.27 mmol)을 무수 테트라하이드로푸란(5 mL)에 녹인후 수소화나트륨(270 mg, 9.8 mmol)을 넣고 1 시간 가량 교반하였다. 그 후 MOM-Cl(810 ㎕, 9.8 mmol)를 가하여 1 시간 동안 반응시켰다. 물을 가하여 반응을 종결시킨 후 염화메틸렌으로 생성물을 추출하고 무수 황산마그네슘으로 물을 제거시킨 후, 여과하여 얻은 염화메틸렌 용액을 감압하에서 농축시키고, 에틸아세테이트와 헥산으로 재결정하여 화합물 3(1.15 g, 수득율≒100 %)을 얻었다.Diol compound 2 (1 g, 3.27 mmol) was dissolved in anhydrous tetrahydrofuran (5 mL) in a 50 mL two-neck round flask under nitrogen atmosphere, and sodium hydride (270 mg, 9.8 mmol) was added thereto, followed by stirring for about 1 hour. . Then MOM-Cl (810 μl, 9.8 mmol) was added and reacted for 1 hour. After completion of the reaction by adding water, the product was extracted with methylene chloride, water was removed with anhydrous magnesium sulfate, and the methylene chloride solution obtained by filtration was concentrated under reduced pressure, and recrystallized with ethyl acetate and hexane to give Compound 3 (1.15 g, Yield # 100%) was obtained.

Rf 값 : 0.48 (EA : Hex = 1 : 3)Rf value: 0.48 (EA: Hex = 1: 3)

1H-NMR(CDCl3,400 MHz) : δ7.20(m, 10H), 7.0(d,J=9.0Hz, 1H), 1 H-NMR (CDCl 3, 400 MHz): δ 7.20 (m, 10H), 7.0 (d, J = 9.0 Hz, 1H),

6.68(dd,J A=8.8Hz,J B=3.2Hz, 1H),6.68 (dd, J A = 8.8 Hz, J B = 3.2 Hz, 1H),

6.07(d,J=2.9Hz, 1H), 4.72(s, 2H),6.07 (d, J = 2.9 Hz, 1H), 4.72 (s, 2H),

3.53(s, 3H), 3.03(s, 3H)3.53 (s, 3H), 3.03 (s, 3H)

[실시예 4] 3-[메톡시(디페닐)메틸]-4-(메톡시메톡시)아니솔의 합성Example 4 Synthesis of 3- [methoxy (diphenyl) methyl] -4- (methoxymethoxy) anisole

질소분위기하에서 50 mL 투-넥 둥근 플라스크에 화합물 3(1.17 g, 3.34 mmol)을 무수 테트라하이드로푸란(10 mL)에 녹인후 수소화나트륨(270 mg, 10 mmol)을 넣고 1 시간 가량 교반하였다. 그 후 요오드메탄(620 ㎕, 10 mmol)를 가하여 1 시간 동안 반응시켰다. 물을 가하여 반응을 종결시킨 후 염화메틸렌으로 생성물을 추출하고 무수 황산마그네슘으로 물을 제거시킨 후, 여과하여 얻은 염화메틸렌 용액을 감압하에서 농축시켜 노란색 액체 화합물 4(1.22 g, 수득율≒100 %)을 얻었다.Compound 3 (1.17 g, 3.34 mmol) was dissolved in anhydrous tetrahydrofuran (10 mL) in a 50 mL two-neck round flask under nitrogen atmosphere, and sodium hydride (270 mg, 10 mmol) was added thereto, followed by stirring for about 1 hour. Thereafter, iodine methane (620 µl, 10 mmol) was added thereto and reacted for 1 hour. After completion of the reaction by adding water, the product was extracted with methylene chloride, water was removed with anhydrous magnesium sulfate, and the methylene chloride solution obtained by filtration was concentrated under reduced pressure to give a yellow liquid compound 4 (1.22 g, yield: 100%). Got it.

Rf 값 : 0.55 (EA : Hex = 1 : 3)Rf value: 0.55 (EA: Hex = 1: 3)

1H-NMR(CDCl3,400 MHz) : δ7.43(m, 10H), 7.41(d,J=3.2Hz, 1H), 7.21(m, 1 H-NMR (CDCl 3, 400 MHz): δ 7.43 (m, 10H), 7.41 (d, J = 3.2 Hz, 1H), 7.21 (m,

6H), 6.95(d,J=9.0Hz, 1H), 6.72(dd,J A=8.8Hz,6H), 6.95 (d, J = 9.0 Hz, 1H), 6.72 (dd, J A = 8.8 Hz,

J B=3.2Hz, 1H), 4.58(s, 2H), 3.77(s, 3H), 3.05(s, J B = 3.2 Hz, 1H, 4.58 (s, 2H), 3.77 (s, 3H), 3.05 (s,

3H), 2.98(s, 3H)3H), 2.98 (s, 3H)

[실시예 5] 5-메톡시-3-[메톡시(디페닐)메틸]-2-(메톡시메톡시) 벤즈알데히드의 합성Example 5 Synthesis of 5-methoxy-3- [methoxy (diphenyl) methyl] -2- (methoxymethoxy) benzaldehyde

질소분위기하에서 50 mL 투-넥 둥근 플라스크에 화합물 4(1.22 g, 3.3 mmol)을 무수 테트라하이드로푸란(20 mL)에 용해시킨 후, - 78 ℃로 온도를 낮추어서t-부틸리튬(7.76 mL, 13.2 mmol)을 넣고 1 시간 가량 교반하였다. 그 후 디메틸포름아미드(1.02 mL, 13.2 mmol)를 가하여 30분 동안 반응시키고, 온도를 상온으로 올려 1 시간 더 반응시켰다. 물을 가하여 반응을 종결시킨 후 염화메틸렌으로 생성물을 추출하고 무수 황산마그네슘으로 물을 제거시킨 후, 여과하여 얻은 염화메틸렌 용액을 감압하에서 농축시켰다. 에틸아세테이트 : 헥산 = 1 : 5 로 플래쉬 칼럼 크로마토그래피를 사용하여 화합물 5(1.1 g, 수득율=85 %)을 얻었다.Compound 4 (1.22 g, 3.3 mmol) was dissolved in anhydrous tetrahydrofuran (20 mL) in a 50 mL two-neck round flask under nitrogen atmosphere, and then the temperature was lowered to -78 ° C to give t -butyllithium (7.76 mL, 13.2 mmol) was added and stirred for about 1 hour. Thereafter, dimethylformamide (1.02 mL, 13.2 mmol) was added thereto, followed by reaction for 30 minutes, and the temperature was increased to room temperature for 1 hour. After completion of the reaction by adding water, the product was extracted with methylene chloride, water was removed with anhydrous magnesium sulfate, and the methylene chloride solution obtained by filtration was concentrated under reduced pressure. Compound 5 (1.1 g, yield = 85%) was obtained by flash column chromatography with ethyl acetate: hexane = 1: 5.

Rf 값 : 0.53 (EA : Hex = 1 : 3)Rf value: 0.53 (EA: Hex = 1: 3)

1H-NMR(CDCl3,400 MHz) : δ10.07(s, 1H), 7.62(d,J=3.2Hz, 1H), 7.50(m, 1 H-NMR (CDCl 3, 400 MHz): δ 10.07 (s, 1H), 7.62 (d, J = 3.2 Hz, 1H), 7.50 (m,

4H), 7.32(m, 5H), 7.23(m, 2H), 4.20(s, 2H),4H), 7.32 (m, 5H), 7.23 (m, 2H), 4.20 (s, 2H),

3.83(s, 3H), 3.27(s, 3H), 3.03(s, 3H)3.83 (s, 3H), 3.27 (s, 3H), 3.03 (s, 3H)

EA : calcd. for C24H24O5(392.16) C=73.44, H=6.17; found C=73.19, H=6.17EA: calcd. for C 24 H 24 O 5 (392.16) C = 73.44, H = 6.17; found C = 73.19, H = 6.17

mp : 123-124 ℃mp: 123-124 ℃

[실시예 6] 2-히드록시-5-메톡시-3-[메톡시(디페닐)메틸]벤즈알데히드와2-히드록시-3-[히드록시(디페닐)메틸]-5-메톡시벤즈알데히드의 합성Example 6 2-hydroxy-5-methoxy-3- [methoxy (diphenyl) methyl] benzaldehyde and 2-hydroxy-3- [hydroxy (diphenyl) methyl] -5-methoxybenzaldehyde Synthesis of

50 mL 투-넥 둥근 플라스크에 화합물 5(1 g, 2.5 mmol)을 넣고 메탄올(5 mL)에 용해시킨 후, 진한 염산 2-3 방울을 가하고 30 분간 가열 환류시켰다. 물을 가하여 반응을 종결시킨 후 염화메틸렌으로 생성물을 추출하고 무수 황산마그네슘으로 물을 제거시킨 후, 여과하여 얻은 염화메틸렌 용액을 감압하에서 농축시켰다. 실리카젤을 이용하여 플래쉬 칼럼 크로마토그래피(에틸아세테이트 : 헥산 = 1 : 5)를 사용하여 화합물 6(260 mg, 수득율=30 %)과 화합물 7(480 mg, 수득율=58 %)을 얻었다.Compound 5 (1 g, 2.5 mmol) was added to a 50 mL two-necked round flask and dissolved in methanol (5 mL). Then, 2-3 drops of concentrated hydrochloric acid was added and heated to reflux for 30 minutes. After completion of the reaction by adding water, the product was extracted with methylene chloride, water was removed with anhydrous magnesium sulfate, and the methylene chloride solution obtained by filtration was concentrated under reduced pressure. Flash column chromatography (ethyl acetate: hexane = 1: 5) using silica gel gave Compound 6 (260 mg, Yield = 30%) and Compound 7 (480 mg, Yield = 58%).

<화합물 6> <Compound 6 >

Rf 값 : 0.5 (EA : Hex = 1 : 3)Rf value: 0.5 (EA: Hex = 1: 3)

1H-NMR(CDCl3,400 MHz) : δ10.55(s, 1H), 10.01(s, 1H), 7.51(d,J=3.2Hz, 1 H-NMR (CDCl 3, 400 MHz): δ 10.55 (s, 1H), 10.01 (s, 1H), 7.51 (d, J = 3.2 Hz,

1H), 7.45(m, 4H), 7.32(m, 6H), 7.0(d,J=3.2Hz,1H), 7.45 (m, 4H), 7.32 (m, 6H), 7.0 (d, J = 3.2 Hz,

1H), 3.8(s, 3H), 3.08(s, 3H)1H), 3.8 (s, 3H), 3.08 (s, 3H)

13C-NMR(CDCl3,400 MHz) : δ193.91, 153.97, 152.17, 140.74, 134.21, 13 C-NMR (CDCl 3, 400 MHz): δ 193.91, 153.97, 152.17, 140.74, 134.21,

128.88, 127.69, 127.48, 124.37, 121.77,128.88, 127.69, 127.48, 124.37, 121.77,

112.14, 59.68, 44.76, 15.14112.14, 59.68, 44.76, 15.14

EA : calcd. for C22H20O4(348.14) C=75.83, H=5.79; found C=75.79, H=5.89EA: calcd. for C 22 H 20 O 4 (348.14) C = 75.83, H = 5.79; found C = 75.79, H = 5.89

mp : 117-128 ℃mp: 117-128 ℃

<화합물 7> <Compound 7 >

Rf 값 : 0.4 (EA : Hex = 1 : 3)Rf value: 0.4 (EA: Hex = 1: 3)

1H-NMR(CDCl3,400 MHz) : δ11.5(s, 1H), 9.87(s, 1H), 7.29(m, 10H), 1 H-NMR (CDCl 3, 400 MHz): δ 11.5 (s, 1H), 9.87 (s, 1H), 7.29 (m, 10H),

6.96(d,J=3.2Hz, 1H), 6.48(d,J=3.2Hz, 1H),6.96 (d, J = 3.2 Hz, 1H), 6.48 (d, J = 3.2 Hz, 1H),

5.25(s, 1H), 3.69(s, 3H)5.25 (s, 1H), 3.69 (s, 3H)

13C-NMR(CDCl3,400 MHz) : δ196.38, 153.84, 151.99, 145.23, 136.70, 13 C-NMR (CDCl 3, 400 MHz): δ 196.38, 153.84, 151.99, 145.23, 136.70,

127.97, 127.56, 127.48, 126.16, 120.27,127.97, 127.56, 127.48, 126.16, 120.27,

113.64, 81.60, 55.65113.64, 81.60, 55.65

EA : calcd. for C21H18O4(334.37) C=75.43, H=5.43; found C=75.23, H=5.43EA: calcd. for C 21 H 18 O 4 (334.37) C = 75.43, H = 5.43; found C = 75.23, H = 5.43

mp : 139-141 ℃mp: 139-141 ℃

[실시예 7] 화합물 8 의 합성Example 7 Synthesis of Compound 8

50 mL 투-넥 둥근 플라스크에 화합물 6(150 mg, 0.43 mmol)과 (1R,2R)-(+)-1,2-디페닐에틸렌디아민(46 mg, 0.22 mmol)을 무수 에탄올(5 mL)에 용해시킨 후, 2시간 동안 가열 환류시켰다. 온도를 상온으로 식힌후 생성된 노란색 고체 화합물을 여과하여 화합물 8(160 mg, 수득율≒99 %)을 얻었다.In a 50 mL two-necked round flask, Compound 6 (150 mg, 0.43 mmol) and ( 1R , 2R )-(+)-1,2-diphenylethylenediamine (46 mg, 0.22 mmol) were dried with anhydrous ethanol (5 mL). After dissolving in, it was heated to reflux for 2 hours. After cooling to room temperature, the resulting yellow solid compound was filtered to obtain compound 8 (160 mg, yield # 99%).

Rf 값 : 0.42 (EA : Hex = 1 : 3)Rf value: 0.42 (EA: Hex = 1: 3)

1H-NMR(CDCl3,400 MHz) : δ12.79(s, 2H), 8.15(s, 2H), 7.44(m, 12H), 1 H-NMR (CDCl 3, 400 MHz): δ 12.79 (s, 2H), 8.15 (s, 2H), 7.44 (m, 12H),

7.22(m, 12H), 7.09(m, 6H), 6.96(m, 4H), 6.55(s,7.22 (m, 12H), 7.09 (m, 6H), 6.96 (m, 4H), 6.55 (s,

2H), 4.50(s, 2H), 3.73(s, 6H), 3.01(s, 6H)2H), 4.50 (s, 2H), 3.73 (s, 6H), 3.01 (s, 6H)

13C-NMR(CDCl3,400 MHz) : δ165.79, 153.00, 151.46, 142.63, 142.15, 13 C-NMR (CDCl 3, 400 MHz): δ 165.79, 153.00, 151.46, 142.63, 142.15,

138.94, 131.65, 128.58, 128.37, 128.17,138.94, 131.65, 128.58, 128.37, 128.17,

127.96, 127.48, 127.39, 126.71,126.64, 119.55,127.96, 127.48, 127.39, 126.71,126.64, 119.55,

118.64, 114.97, 85.66, 80.55, 55.85, 52.10118.64, 114.97, 85.66, 80.55, 55.85, 52.10

EA : calcd. for C58H52O6N2(873.06) C=79.79, H=6.00, N=3.21;EA: calcd. for C 58 H 52 O 6 N 2 (873.06) C = 79.79, H = 6.00, N = 3.21;

found C=79.57, H=6.04, N=3.16found C = 79.57, H = 6.04, N = 3.16

mp : 127-139 ℃mp: 127-139 ℃

[실시예 8] 화합물 9 의 합성Example 8 Synthesis of Compound 9

50 mL 투-넥 둥근 플라스크에 화합물 7(300 mg, 0.9 mmol)과 (1R,2R)-(+)-1,2-디페닐에틸렌디아민(95 mg, 0.45 mmol)을 무수 에탄올(5 mL)에 용해시킨 후, 2시간 동안 가열 환류시켰다. 온도를 상온으로 식힌후 생성된 노란색 고체 화합물을 여과하여 화합물 9(308 mg, 수득율=97 %)을 얻었다.In a 50 mL two-neck round flask, compound 7 (300 mg, 0.9 mmol) and (1R, 2R)-(+)-1,2-diphenylethylenediamine (95 mg, 0.45 mmol) were dried with anhydrous ethanol (5 mL). After dissolving in, it was heated to reflux for 2 hours. After cooling to room temperature, the resulting yellow solid compound was filtered to give compound 9 (308 mg, yield = 97%).

Rf 값 : 0.32(EA : Hex = 1 : 3)Rf value: 0.32 (EA: Hex = 1: 3)

1H-NMR(CDCl3,400 MHz) : δ13.84(s, 2H), 8.26(s, 2H), 7.28(m, 20H), 1 H-NMR (CDCl 3, 400 MHz): δ 13.84 (s, 2H), 8.26 (s, 2H), 7.28 (m, 20H),

7.15(m, 6H), 7.03(m, 4H), 6.57(d,J=3.2Hz, 2H),7.15 (m, 6H), 7.03 (m, 4H), 6.57 (d, J = 3.2 Hz, 2H),

6.22(d,J=2.9Hz, 2H), 5.88(s, 2H), 4.61(s, 2H),6.22 (d, J = 2.9 Hz, 2H), 5.88 (s, 2H), 4.61 (s, 2H),

3.61(s, 6H)3.61 (s, 6H)

13C-NMR(CDCl3,400 MHz) : δ166.19, 153.48, 151.18, 146.23, 145.89, 13 C-NMR (CDCl 3, 400 MHz): δ 166.19, 153.48, 151.18, 146.23, 145.89,

138.32, 135.27, 129.43, 127.87, 127.84,138.32, 135.27, 129.43, 127.87, 127.84,

127.80, 137.73, 127.17, 127.14, 118.08,127.80, 137.73, 127.17, 127.14, 118.08,

113.59, 81.97, 79.76, 55.59113.59, 81.97, 79.76, 55.59

IR(KBr) : 3494, 3059, 3028, 2935, 1630, 1598, 1459, 1031cm-1 IR (KBr): 3494, 3059, 3028, 2935, 1630, 1598, 1459, 1031 cm -1

EA : calcd. for C56H48O6N2(845.01) C=79.60, H=5.73, N=3.32;EA: calcd. for C 56 H 48 O 6 N 2 (845.01) C = 79.60, H = 5.73, N = 3.32;

found C=79.85, H=5.75, N=3.32found C = 79.85, H = 5.75, N = 3.32

mp : 192-200 ℃mp: 192-200 ℃

[실시예 9] 화합물 10 (촉매)의 합성Example 9 Synthesis of Compound 10 (Catalyst)

50 mL 투-넥 둥근 플라스크에 화합물 8(45 mg, 0.063 mmol)을 무수 에탄올(5 mL)에 용해시킨 후, 망간(Ⅱ)아세테이트(22 mg, 0.125 mmol)를 넣고 2 시간 동안 가열 환류시켰다. 그 후 여기에 리튬 클로라이드를 (5 mg, 0.125 mmol)을 가한 후 1 시간 동안 가열 환류시켰다. 온도를 상온으로 식힌후 물을 가하여 생성된 갈색 고체 화합물을 여과하여 화합물 10(39 mg, 수득율=80 %)을 얻었다.Compound 8 (45 mg, 0.063 mmol) was dissolved in anhydrous ethanol (5 mL) in a 50 mL two-necked round flask, and manganese (II) acetate (22 mg, 0.125 mmol) was added thereto and heated to reflux for 2 hours. Then lithium chloride (5 mg, 0.125 mmol) was added thereto and then heated to reflux for 1 hour. After cooling to room temperature, water was added to the resulting brown solid compound, which was filtered to give compound 10 (39 mg, yield = 80%).

IR(KBr) : 3057, 2931, 1611, 1542, 1449, 1415, 1060cm-1 IR (KBr): 3057, 2931, 1611, 1542, 1449, 1415, 1060cm -1

EA : calcd. for C58H50O6N2MnCl (961.44) C=72.46, H=5.24, N=2.91;EA: calcd. for C 58 H 50 O 6 N 2 MnCl (961.44) C = 72.46, H = 5.24, N = 2.91;

found C=71.72, H=5.69, N=2.67found C = 71.72, H = 5.69, N = 2.67

mp : 195-200 ℃mp: 195-200 ℃

[실시예 10] 화합물 11 (촉매)의 합성Example 10 Synthesis of Compound 11 (Catalyst)

50 mL 투-넥 둥근 플라스크에 화합물 9(200 mg, 0.28 mmol)을 무수 에탄올(10 mL)에 용해시킨 후, 망간(Ⅱ)아세테이트(98 mg, 0.57 mmol)를 넣고 2 시간 동안 가열 환류시켰다. 그 후 여기에 리튬 클로라이드(24 mg, 0.57 mmol)를 가한 후 1시간 동안 가열 환류시켰다. 온도를 상온으로 식힌 후 물을 가한후 생성된 갈색 고체 화합물을 여과하여 화합물 11(200 mg, 수득율=94 %)을 얻었다.Compound 9 (200 mg, 0.28 mmol) was dissolved in anhydrous ethanol (10 mL) in a 50 mL two-necked round flask, and manganese (II) acetate (98 mg, 0.57 mmol) was added thereto and heated to reflux for 2 hours. Then lithium chloride (24 mg, 0.57 mmol) was added thereto and then heated to reflux for 1 hour. After cooling to room temperature, water was added and the resulting brown solid compound was filtered to give compound 11 (200 mg, yield = 94%).

IR(KBr) : 3437, 3058, 3030, 2932, 1609, 1547, 1449, 1039, 1018cm-1 IR (KBr): 3437, 3058, 3030, 2932, 1609, 1547, 1449, 1039, 1018 cm -1

EA : calcd. for C56H46O6N2MnCl(933.38) C=72.06, H=4.97, N=3.00;EA: calcd. for C 56 H 46 O 6 N 2 MnCl (933.38) C = 72.06, H = 4.97, N = 3.00;

found C=70.68, H=5.24, N=2.86found C = 70.68, H = 5.24, N = 2.86

mp : 220-230 ℃mp: 220-230 ℃

[실시예 11] 2-(1'-에틸-1'-히드록시프로필)-4-메톡시페놀의 합성Example 11 Synthesis of 2- (1'-ethyl-1'-hydroxypropyl) -4-methoxyphenol

질소분위기하에서 50 mL 투-넥 둥근 플라스크에 마그네슘(640 mg, 26.5 mmol)을 넣고 토치를 이용하여 건조시킨후, 테트라하이드로푸란(10 mL)와 브로모에탄(2 mL, 26.5 mmol)을 가하여 1 시간 동안 반응시켜 에틸마그네슘브로마이드 (EtMgBr) 용액을 만들었다.Magnesium (640 mg, 26.5 mmol) was added to a 50 mL two-neck round flask under nitrogen atmosphere, and dried using a torch. Then, tetrahydrofuran (10 mL) and bromoethane (2 mL, 26.5 mmol) were added thereto. The reaction was carried out for a period of time to give an ethyl magnesium bromide (EtMgBr) solution.

질소분위기하에서 50 mL 투-넥 둥근 플라스크에 화합물 1(1.06 g, 5.88 mmol)을 무수 테트라하이드로푸란(5 mL)에 용해시킨 후, 상기에서 제조한 에틸마그네슘브로마이드 용액을 서서히 넣고 1 시간 동안 상온에서 교반하였다. 1 N HCl을 넣어 반응종결후 염화메틸렌으로 생성물을 추출하고 무수황산마그네슘으로 물을 제거시킨 후, 여과하여 얻은 염화메틸렌 용액을 감압하에서 농축시켜 화합물인 다이올 12(1.24 g, 수득율≒100 %)을 얻었다.Compound 1 (1.06 g, 5.88 mmol) was dissolved in anhydrous tetrahydrofuran (5 mL) in a 50 mL two-neck round flask under nitrogen atmosphere, and the ethylmagnesium bromide solution prepared above was slowly added thereto at room temperature for 1 hour. Stirred. After completion of the reaction by adding 1 N HCl, the product was extracted with methylene chloride, water was removed with anhydrous magnesium sulfate, and the filtered methylene chloride solution was concentrated under reduced pressure to obtain a compound diol 12 (1.24 g, yield: 100%). Got.

Rf 값 : 0.47 (EA : Hex = 1 : 3)Rf value: 0.47 (EA: Hex = 1: 3)

1H-NMR(CDCl3,400 MHz) : δ9.09(s, 1H), 6.77(d,J=8.8Hz, 1H), 1 H-NMR (CDCl 3, 400 MHz): δ 9.09 (s, 1H), 6.77 (d, J = 8.8 Hz, 1H),

6.71(dd,J A=8.8Hz,J B=2.9Hz, 1H),6.71 (dd, J A = 8.8 Hz, J B = 2.9 Hz, 1H),

6.48(d,J=2.9Hz, 1H), 3.74(s, 3H),6.48 (d, J = 2.9 Hz, 1H), 3.74 (s, 3H),

2.50(s, 1H), 1.94(m, 2H), 1.83(m, 2H),2.50 (s, 1 H), 1.94 (m, 2 H), 1.83 (m, 2 H),

0.88(t,J=7.56Hz, 6H)0.88 (t, J = 7.56 Hz, 6H)

EA : calcd. for C12O18O3(210.27) C=68.55, H=8.63; found C=68.66, H=8.78EA: calcd. for C 12 O 18 O 3 (210.27) C = 68.55, H = 8.63; found C = 68.66, H = 8.78

mp : 90-92 ℃mp: 90-92 ℃

[실시예 12] 3-(1'-에틸-1'-히드록시프로필)-4-(메톡시메톡시)아니솔의 합성Example 12 Synthesis of 3- (1'-ethyl-1'-hydroxypropyl) -4- (methoxymethoxy) anisole

화합물 2(500 mg, 2.38 mmol)과 수소화나트륨(23 mg, 8.32 mmol), MOM-Cl(686 ㎕, 8.32 mmol)을 사용하여 실시예 3 과 동일한 방법으로 실험하여 화합물 3(560 mg, 수득율=93 %)을 얻었다.Using Compound 2 (500 mg, 2.38 mmol), sodium hydride (23 mg, 8.32 mmol) and MOM-Cl (686 μl, 8.32 mmol) in the same manner as in Example 3, compound 3 (560 mg, yield = 93%).

Rf 값 : 0.5 (EA : Hex = 1 : 3)Rf value: 0.5 (EA: Hex = 1: 3)

1H-NMR(CDCl3,400 MHz) : δ7.06(d,J=9.0Hz, 1H), 6.92(d,J=3.0, 1H), 1 H-NMR (CDCl 3, 400 MHz): δ 7.06 (d, J = 9.0 Hz, 1H), 6.92 (d, J = 3.0, 1H),

6.71(dd,J A=9.1Hz,J B=3.0Hz, 1H), 5.17(s, 2H),6.71 (dd, J A = 9.1 Hz, J B = 3.0 Hz, 1H), 5.17 (s, 2H),

3.77(s, 3H), 3.51(s, 1H), 3.49(s, 3H), 2.04(m,3.77 (s, 3H), 3.51 (s, 1H), 3.49 (s, 3H), 2.04 (m,

2H), 1.81(m, 2H), 0.79(t,J=7.6Hz, 6H)2H), 1.81 (m, 2H), 0.79 (t, J = 7.6 Hz, 6H)

EA : calcd. for C14H22O4(254.33) C=66.12, H=8.72; found C=62.04, H=8.52EA: calcd. for C 14 H 22 O 4 (254.33) C = 66.12, H = 8.72; found C = 62.04, H = 8.52

[실시예 13] 3-(1'-에틸-1'-메톡시프로필)-4-(메톡시메톡시)아니솔의 합성Example 13 Synthesis of 3- (1'-ethyl-1'-methoxypropyl) -4- (methoxymethoxy) anisole

화합물 13(450 mg, 1.77 mmol)과 수소화칼륨(210 mg, 5.32 mmol), 요오드메탄(330 ㎕, 5.32 mmol)을 사용하여 실시예 4 와 동일한 방법으로 실험하여 화합물 14(475 mg, 수득율=95 %)을 얻었다.Using Compound 13 (450 mg, 1.77 mmol), potassium hydride (210 mg, 5.32 mmol) and iodine methane (330 μl, 5.32 mmol) in the same manner as in Example 4, compound 14 (475 mg, yield = 95 %) Was obtained.

Rf 값 : 0.67 (EA : Hex = 1 : 3)Rf value: 0.67 (EA: Hex = 1: 3)

1H-NMR(CDCl3,400 MHz) : δ7.17(d,J=3.2Hz, 1H), 7.02(d,J=9.0Hz, 1H), 1 H-NMR (CDCl 3, 400 MHz): δ7.17 (d, J = 3.2 Hz, 1H), 7.02 (d, J = 9.0 Hz, 1H),

6.70(dd,J A=8.9Hz,J B=3.2Hz, 1H), 5.11(s, 2H),6.70 (dd, J A = 8.9 Hz, J B = 3.2 Hz, 1H), 5.11 (s, 2H),

3.78(s, 3H), 3.47(s, 3H), 3.19(s, 3H), 2.1(m,3.78 (s, 3H), 3.47 (s, 3H), 3.19 (s, 3H), 2.1 (m,

2H), 1.92(m, 2H), 0.62(t,J=7.3Hz, 6H)2H), 1.92 (m, 2H), 0.62 (t, J = 7.3 Hz, 6H)

EA : calcd. for C15H24O4(268.35) C=67.14, H=9.01; found C=67.17, H=9.03EA: calcd. for C 15 H 24 O 4 (268.35) C = 67.14, H = 9.01; found C = 67.17, H = 9.03

[실시예 14] 3-(1'-에틸-1'-메톡시프로필)-5-메톡시-2-(메톡시메톡시)벤즈알데히드의 합성Example 14 Synthesis of 3- (1'-ethyl-1'-methoxypropyl) -5-methoxy-2- (methoxymethoxy) benzaldehyde

화합물 14(420 mg, 1.57 mmol)과t-부틸리튬(7 mL, 6.28 mmol), 디메틸포름아미드(486 ㎕, 6.28 mmol)을 사용하여 실시예 5 와 동일한 방법으로 실험하여 화합물 15(335 mg, 수득율=72 %)을 얻었다.Using Compound 14 (420 mg, 1.57 mmol), t -butyllithium (7 mL, 6.28 mmol) and dimethylformamide (486 μl, 6.28 mmol) in the same manner as in Example 5, compound 15 (335 mg, Yield = 72%).

Rf 값 : 0.53 (EA : Hex = 1 : 3)Rf value: 0.53 (EA: Hex = 1: 3)

1H-NMR(CDCl3,400 MHz) : δ10.25(s, 1H), 7.37(d,J=3.4Hz, 1H), 7.25(d, 1 H-NMR (CDCl 3, 400 MHz): δ 10.25 (s, 1 H), 7.37 (d, J = 3.4 Hz, 1 H), 7.25 (d,

J=3.2Hz, 1H), 4.95(s, 2H), 3.83(s, 3H), 3.60(s, J = 3.2 Hz, 1H, 4.95 (s, 2H), 3.83 (s, 3H), 3.60 (s,

3H), 3.12(s, 3H), 2.04(m, 4H), 0.67(t,J=7.3Hz,3H), 3.12 (s, 3H), 2.04 (m, 4H), 0.67 (t, J = 7.3 Hz,

6H)6H)

13C-NMR(CDCl3,400 MHz) : δ191.33, 155.54, 153.11, 138.86, 131.23, 13 C-NMR (CDCl 3, 400 MHz): δ 191.33, 155.54, 153.11, 138.86, 131.23,

124.15, 108.64, 102.02, 81.23, 57.49, 55.57,124.15, 108.64, 102.02, 81.23, 57.49, 55.57,

48.81, 26.17, 7.7948.81, 26.17, 7.79

EA : calcd. for C16H24O5(296.36) C=64.84, H=8.16; found C=64.63, H=8.29EA: calcd. for C 16 H 24 O 5 (296.36) C = 64.84, H = 8.16; found C = 64.63, H = 8.29

[실시예 15] 3-(1'-에틸-1'-메톡시프로필)-2-히드록시-5-메톡시벤즈알데히드의 합성Example 15 Synthesis of 3- (1'-ethyl-1'-methoxypropyl) -2-hydroxy-5-methoxybenzaldehyde

화합물 15(170 mg, 0.57 mmol)를 사용하여 실시예 6 과 동일한 방법으로 실험하여 화합물 16(138 mg, 수득율=96 %)을 얻었다.Using Compound 15 (170 mg, 0.57 mmol) in the same manner as in Example 6, Compound 16 (138 mg, yield = 96%) was obtained.

Rf 값 : 0.62 (EA : Hex = 1 : 3)Rf value: 0.62 (EA: Hex = 1: 3)

1H-NMR(CDCl3,400 MHz) : δ10.59(s, 1H), 10.13(s, 1H), 7.25(d,J=3.16Hz, 1 H-NMR (CDCl 3, 400 MHz): δ 10.59 (s, 1H), 10.13 (s, 1H), 7.25 (d, J = 3.16 Hz,

1H), 7.02(d,J=3.16Hz, 1H), 3.81(s, 3H), 3.241H), 7.02 (d, J = 3.16 Hz, 1H), 3.81 (s, 3H), 3.24

(s, 3H), 2.08(m, 2H), 1.93(m, 2H), 0.68(t,(s, 3H), 2.08 (m, 2H), 1.93 (m, 2H), 0.68 (t,

J=7.56Hz, 6H) J = 7.56 Hz, 6H)

13C-NMR(CDCl3,400 MHz) : δ193.83, 154.26, 152.13, 131.99, 124.97, 13 C-NMR (CDCl 3, 400 MHz): δ 193.83, 154.26, 152.13, 131.99, 124.97,

121.46, 111.07, 83.37, 55.76, 48.68, 26.07,121.46, 111.07, 83.37, 55.76, 48.68, 26.07,

7.667.66

Mass(EI)m/z: 252.14, 222.11, 191,07, 163.00, 135.00Mass (EI) m / z : 252.14, 222.11, 191,07, 163.00, 135.00

HRMS : calcd. for 252.1362 (C5H20O4); found 252.1368HRMS: calcd. for 252.1362 (C 5 H 20 O 4 ); found 252.1368

[실시예 16] 화합물 17 의 합성Example 16 Synthesis of Compound 17

화합물 16(110 mg, 0.44 mmol)과 (1R,2R)-(+)-1,2-디페닐에틸렌디아민(46 mg, 0.22 mmol), 무수 에탄올(5 mL)을 사용하여 실시예 7 과 동일한 방법으로 실험하여 화합물 17(135 mg, 수득율=91 %)을 얻었다.Same as Example 7 using compound 16 (110 mg, 0.44 mmol), ( 1R , 2R )-(+)-1,2-diphenylethylenediamine (46 mg, 0.22 mmol), anhydrous ethanol (5 mL) Experimented by the method, compound 17 (135 mg, yield = 91%) was obtained.

Rf 값 : 0.58 (EA : Hex = 1 : 3)Rf value: 0.58 (EA: Hex = 1: 3)

1H-NMR(CDCl3,400 MHz) : δ13.18(s, 2H), 8.28(s, 2H), 7.20(m, 10H), 1 H-NMR (CDCl 3, 400 MHz): δ 13.18 (s, 2H), 8.28 (s, 2H), 7.20 (m, 10H),

7.17(d,J=2.9Hz, 2H), 6.51(d,J=3.2Hz, 2H),7.17 (d, J = 2.9 Hz, 2H), 6.51 (d, J = 3.2 Hz, 2H),

4.65(s, 2H), 3.68(s, 6H), 3.14(s, 6H), 2.22(m,4.65 (s, 2H), 3.68 (s, 6H), 3.14 (s, 6H), 2.22 (m,

4H), 1.9(m, 4H), 0.57(t,J=7.3Hz, 3H), 0.50(t,4H), 1.9 (m, 4H), 0.57 (t, J = 7.3 Hz, 3H), 0.50 (t,

J=7.3Hz, 3H) J = 7.3 Hz, 3H)

13C-NMR(CDCl3,400 MHz) : δ166.38, 152.48, 151.21, 139.21, 132.10, 13 C-NMR (CDCl 3, 400 MHz): δ 166.38, 152.48, 151.21, 139.21, 132.10,

128.33, 128.02, 127.58, 120.62, 117.70, 113.22,128.33, 128.02, 127.58, 120.62, 117.70, 113.22,

81.28, 80.56, 55.63, 48.29, 25.43, 7.81, 7.7481.28, 80.56, 55.63, 48.29, 25.43, 7.81, 7.74

IR(KBr) : 3470, 2964, 2931, 2877, 2828, 1630, 1625, 1596, 1453, 1077cm-1 IR (KBr): 3470, 2964, 2931, 2877, 2828, 1630, 1625, 1596, 1453, 1077 cm -1

EA : calcd. for C42H52O6N2(680.88) C=74.09, H=7.70, N=4.11;EA: calcd. for C 42 H 52 O 6 N 2 (680.88) C = 74.09, H = 7.70, N = 4.11;

found C=74.20, H=7.83, N=4.03found C = 74.20, H = 7.83, N = 4.03

mp : 94-130 ℃mp: 94-130 ℃

[실시예 17] 화합물 18 (촉매)의 합성Example 17 Synthesis of Compound 18 (Catalyst)

화합물 17(200 mg, 0.3 mmol)과 망간(Ⅱ)아세테이트(104 mg, 0.6 mmol), 리튬 클로라이드(64 mg, 1.5 mmol)를 사용하여 실시예 9 및 10 과 동일한 방법으로 실험하여 갈색 고체 화합물의 화합물 18(217 mg, 수득율=98 %)을 얻었다.Using the compound 17 (200 mg, 0.3 mmol), manganese (II) acetate (104 mg, 0.6 mmol), lithium chloride (64 mg, 1.5 mmol) in the same manner as in Examples 9 and 10 to give a brown solid compound Compound 18 (217 mg, yield = 98%) was obtained.

IR(KBr) : 2963, 2932, 1605, 1544, 1413, 1355, 1078cm-1 IR (KBr): 2963, 2932, 1605, 1544, 1413, 1355, 1078 cm -1

EA : calcd. for C42H50O6N2MnCl (769.26) C=65.58, H=6.55, N=3.64;EA: calcd. for C 42 H 50 O 6 N 2 MnCl (769.26) C = 65.58, H = 6.55, N = 3.64;

found C=64.59, H=7.14, N=3.21found C = 64.59, H = 7.14, N = 3.21

mp : 210-212 ℃mp: 210-212 ℃

[실시예 18] 촉매 10 을 이용한 스티렌옥사이드의 합성(NaOCl 산화제)Example 18 Synthesis of Styrene Oxide Using Catalyst 10 (NaOCl Oxidizer)

20 mL 샘플병 (vial) 에 무수 염화메틸렌(1 mL)를 넣고 온도를 0 ℃ 로 낮춘 후 여기에 스티렌(20 ㎕, 0.17 mmol)과 4-페닐피리딘-N-옥사이드(6 mg, 0.034mmol)를 넣었다. 촉매인 화합물 10(5 mg, 0.00698 mmol)을 가하여 용해시킨 후, NaOCl(0.35 mmol)[0.05 M Na2HPO4완충용액(260 ㎕)과 12 % NaOCl(217 ㎕)를 섞은 후 진한 염산을 이용하여 pH=11.3 이 되도록 맞춘다]를 가하여 0 ℃에서 4 시간 동안 반응시킨 후 유기층을 취하고, 여기에 헥산을 이용하여 셀라이트 여과 (celite filter) 하였다. 용액의 일부를 택하여 GC 를 측정하고, 그것으로부터 수율과 e.e 값을 구하였다.Anhydrous methylene chloride (1 mL) was added to a 20 mL vial, and the temperature was lowered to 0 ° C., followed by styrene (20 μl, 0.17 mmol) and 4-phenylpyridine- N -oxide (6 mg, 0.034 mmol). Put it. After dissolving by adding 10 (5 mg, 0.00698 mmol) as a catalyst, NaOCl (0.35 mmol) [0.05 M Na 2 HPO 4 buffer solution (260 μL) and 12% NaOCl (217 μL) were mixed and concentrated hydrochloric acid was used. To adjust pH = 11.3] and the reaction was carried out at 0 ° C. for 4 hours, and the organic layer was taken, and filtered through celite using hexane. A portion of the solution was taken to measure GC, from which yield and ee values were obtained.

수득율 = 11 %Yield = 11%

%e.e = 29 %% e.e = 29%

GC retention time(min) : 8.94(styrene), 23.22((R)-styrene oxide),GC retention time (min): 8.94 (styrene), 23.22 (( R ) -styrene oxide),

23.77((S)-styrene oxide)23.77 (( S ) -styrene oxide)

GC condition : Supelco chiral cyclo β-Dex 325 column, N2carrier gas,GC condition Supelco chiral cyclo β-Dex 325 column, N2carrier gas,

10 psi, 90 ℃(5min), 1 ℃/min, 120 ℃(10), injection10 psi, 90 ° C (5 min), 1 ° C / min, 120 ° C (10), injection

temp = 150 ℃, detection temp = 170 ℃temp = 150 ℃, detection temp = 170 ℃

[실시예 19] 촉매 10 을 이용한 스티렌옥사이드의 합성(mCPBA산화제)Example 19 Synthesis of Styrene Oxide Using Catalyst 10 ( m CPBA Oxidizer)

질소분위기 하에서 무수 염화메틸렌(1 mL)를 넣고 - 78 ℃를 낮춘 후 여기에 스티렌(10 ㎕, 0.087 mmol)과 4-메틸모르핀-N-옥사이드(51 mg, 0.436 mmol)를 넣었다. 촉매인 화합물 10(3 mg, 0.0035 mmol)을 가하여 용해시킨 후, m-클로로퍼옥시벤조산 (이하,mCPBA 라고 함)(30 mg, 0.174 mmol)를 넣어 -78℃에서 2 시간동안 반응시켰다. 티오아니솔 (Thioanisole) (10 ㎕, 0.087 mmol)을 가하여 반응을 종료시킨 후(- 78 ℃에서 30 분) 온도를 상온으로 올려 30 분간 더 반응시킨후 유기층을 취하고, 여기에 헥산을 가한 후 셀라이트 여과하였다. 용액의 일부를 택하여 GC 를 측정하고, 그것으로부터 수율과 e.e 값을 구하였다.Anhydrous methylene chloride (1 mL) was added under nitrogen atmosphere, and after 78 ° C., styrene (10 μl, 0.087 mmol) and 4-methylmorphine- N -oxide (51 mg, 0.436 mmol) were added thereto. Compound 10 (3 mg, 0.0035 mmol), a catalyst, was added and dissolved, followed by adding m-chloroperoxybenzoic acid (hereinafter referred to as m CPBA) (30 mg, 0.174 mmol) for 2 hours at -78 ° C. After completion of the reaction by adding thioanisole (10 μl, 0.087 mmol) (−30 ° C. at 30 ° C.), the reaction mixture was heated to room temperature for 30 minutes, and then an organic layer was added thereto. Light filtration. A portion of the solution was taken to measure GC, from which yield and ee values were obtained.

수득율 = 6 %Yield = 6%

%e.e = 36 %% e.e = 36%

[실시예 20] 촉매 11 을 이용한 스티렌옥사이드의 합성(NaOCl 산화제)Example 20 Synthesis of Styrene Oxide Using Catalyst 11 (NaOCl Oxidizer)

촉매 11(5 mg, 0.00698 mmol)과 NaOCl(0.35 mmol)을 사용하여 실시예 18과 동일한 방법으로 실험하였다.Experiment was carried out in the same manner as in Example 18, using Catalyst 11 (5 mg, 0.00698 mmol) and NaOCl (0.35 mmol).

수득율 = 54 %Yield = 54%

%e.e = 22 %% e.e = 22%

[실시예 21] 촉매 11 을 이용한 스티렌옥사이드의 합성(mCPBA산화제)Example 21 Synthesis of Styrene Oxide Using Catalyst 11 (mCPBA Oxidation Agent)

촉매 11(3 mg, 0.0035 mmol)과mCPBA(30 mg, 0.174 mmol)을 사용하여 실시예 19 와 동일한 방법으로 실험하였다.Experiment was carried out in the same manner as in Example 19, using Catalyst 11 (3 mg, 0.0035 mmol) and m CPBA (30 mg, 0.174 mmol).

수득율 = 94 %Yield = 94%

%e.e = 28 %% e.e = 28%

[실시예 22] 촉매 18 을 이용한 스티렌옥사이드의 합성(NaOCl 산화제)Example 22 Synthesis of Styrene Oxide Using Catalyst 18 (NaOCl Oxidizer)

촉매인 화합물 18(3 mg, 0.0035 mmol)과 NaOCl(0.35 mmol)을 사용하여 실시예 18 과 동일한 방법으로 실험하였다.Using the compound 18 (3 mg, 0.0035 mmol) and NaOCl (0.35 mmol) as a catalyst in the same manner as in Example 18.

수득율 = 47 %Yield = 47%

%e.e = 72 %% e.e = 72%

[실시예 22] 촉매 18 을 이용한 스티렌옥사이드의 합성(mCPBA 산화제)Example 22 Synthesis of Styrene Oxide Using Catalyst 18 ( m CPBA Oxidizer)

촉매인 화합물 18(3 mg, 0.0035 mmol)과mCPBA(30 mg, 0.174 mmol)을 사용하여 실시예 19 와 동일한 방법으로 실험하였다.Using the compound 18 (3 mg, 0.0035 mmol) and m CPBA (30 mg, 0.174 mmol) as a catalyst in the same manner as in Example 19.

수득율 = 89 %Yield = 89%

%e.e = 82 %% e.e = 82%

[실시예 23] 촉매 18 을 이용한 스티렌옥사이드의 합성(LiOCl 산화제)Example 23 Synthesis of Styrene Oxide Using Catalyst 18 (LiOCl Oxidizer)

20 mL 샘플병에 무수 염화메틸렌(1 mL)를 넣고 온도를 0 ℃로 낮춘 후 여기에 스티렌(10 ㎕, 0.087 mmol)과 4-페닐피리딘-N-옥사이드(3 mg, 0.0174 mmol)를 넣었다. 망간(Ⅲ)촉매인 화합물 18(3 mg, 0.0035 mmol)을 가하여 용해시킨 후, LiOCl(0.174 mmol) [증류수에 70 % LiOCl(15 mg)를 용해시킨 후, 진한 염산을 이용하여 pH=11.3 이 되도록 한다] 를 가하여 0 ℃에서 2 시간 동안 반응시킨 후 유기층을 취하고, 여기에 헥산을 가한 후 셀라이트 여과하였다. 용액의 일부를 택하여 GC 를 측정하고, 그것으로부터 수율과 e.e값을 구하였다.Anhydrous methylene chloride (1 mL) was added to a 20 mL sample bottle, and the temperature was lowered to 0 ° C., followed by styrene (10 μl, 0.087 mmol) and 4-phenylpyridine- N -oxide (3 mg, 0.0174 mmol). After dissolving compound 18 (3 mg, 0.0035 mmol) as a manganese (III) catalyst, LiOCl (0.174 mmol) [70% LiOCl (15 mg) was dissolved in distilled water, and then pH = 11.3 was dissolved using concentrated hydrochloric acid. After the reaction was carried out at 0 ° C. for 2 hours, the organic layer was taken, hexane was added thereto, and the mixture was filtered through Celite. A portion of the solution was taken to measure GC, and yields and ee values were determined therefrom.

수득율 = 99 %Yield = 99%

%e.e = 87 %% e.e = 87%

[실시예 24] 촉매 18을 이용한cis-β-메틸스티렌옥사이드의 합성(LiOCl 산화제)Example 24 Synthesis of cis -β-methylstyrene Oxide Using Catalyst 18 (LiOCl Oxidizer)

cis-β-메틸스티렌(6 ㎕, 0.087 mmol)과 LiOCl(0.174 mmol)을 사용하여 위와 동일한 방법으로 실험하였다. The experiment was carried out in the same manner using cis- β-methylstyrene (6 μl, 0.087 mmol) and LiOCl (0.174 mmol).

수득율 = 100 %Yield = 100%

%e.e = 99 %(cis/trans=20)% e.e = 99% (cis / trans = 20)

GC retention time(min) : 14.22(cis-β-methylstyrene),GC retention time (min): 14.22 ( cis -β-methylstyrene),

27.16((R,S)-cis-β-methylstyrene oxide), 27.16 ((R, S)-cis-β-methylstyrene oxide),

28.48((S,R)-cis-β-methylstyrene oxide), 28.48 ((S, R) - cis- β-methylstyrene oxide),

26.74(trans-β-methylstyrene oxides)26.74 ( trans -β-methylstyrene oxides)

GC condition : Supelco chiral cyclo β-Dex 325 column, N2carrier gas,GC condition Supelco chiral cyclo β-Dex 325 column, N2carrier gas,

10 psi, 90 ℃(5 min), 1 ℃/min, 120 ℃(10), injection10 psi, 90 ° C (5 min), 1 ° C / min, 120 ° C (10), injection

temp = 150 ℃, detection temp = 170 ℃temp = 150 ℃, detection temp = 170 ℃

[실시예 25] 촉매 18 을 이용한 인덴의 에폭시화 반응 (LiOCl 산화제)Example 25 Epoxidation of Indene Using Catalyst 18 (LiOCl Oxidizer)

인덴(65 ㎕, 0.5 mmol)과 4-페닐피리딘-N-옥사이드(17 mg, 0.1 mmol), 화합물9(15 mg, 0.02 mmol), LiOCl(58 mg, 1 mmol)을 사용하여 위와 동일한 방법으로 4 시간동안 반응시켰다.Indene (65 μl, 0.5 mmol), 4-phenylpyridine- N -oxide (17 mg, 0.1 mmol), compound 9 (15 mg, 0.02 mmol), LiOCl (58 mg, 1 mmol) The reaction was carried out for 4 hours.

Rf 값 : 0.48 (EA : Hex = 1 : 4)Rf value: 0.48 (EA: Hex = 1: 4)

수득율 = 95 %Yield = 95%

%e.e = 96 %% e.e = 96%

HPLC retention time(min) : 13.7(R,S), 15.6(S,R)HPLC retention time (min): 13.7 ( R , S ), 15.6 ( S , R )

HPLC condition : (R,R)-Whelk-O1 5㎛,HPLC condition: ( R, R ) -Whelk-O1 5㎛,

4.6 ×250㎜ with CN guard 10 % CHCl3in hexane,4.6 × 250 mm with CN guard 10% CHCl 3 in hexane,

1.0 mL/min, 20 ℃, 254㎚1.0 mL / min, 20 ° C., 254 nm

1H-NMR(CDCl3,300 MHz) : δ7.50(d,J=6.9Hz, 1H), 7.30-7.10(m, 3H), 1 H-NMR (CDCl 3, 300 MHz): δ 7.50 (d, J = 6.9 Hz, 1H), 7.30-7.10 (m, 3H),

4.26(d,J=2.7Hz, 1H), 4.13(t,J=2.7Hz, 1H),4.26 (d, J = 2.7 Hz, 1H), 4.13 (t, J = 2.7 Hz, 1H),

3.21(d,J=18.0Hz, 1H),3.21 (d, J = 18.0 Hz, 1H),

2.97(dd,J A=3.0Hz,J B=17.7Hz, 1H)2.97 (dd, J A = 3.0 Hz, J B = 17.7 Hz, 1H)

본 발명에 따르면, 화학식 1 의 화합물을 입체선택성 에폭시화 반응의 촉매로 이용하여, 높은 입체선택성을 갖는 에폭시 화합물을 합성할 수 있다. 본 발명에 따라 만들어진 키랄 에폭시 화합물들은 의약품 합성에 유용한 중간체로 쓰일수 있다. 예를 들면, 항바이러스 치료제에 활용될 수 있는 인덴 옥사이드의 높은 입체선택성은 기존에 보고된 결과보다 훨씬 진보적인 것으로 평가되며, 고혈압 치료제의 핵심 중간체인 에폭시크로멘(epoxychromene) 유도체 역시 뛰어난 입체선택성을 나타낸다. 또한, 본 발명에 따른 화학식 1 의 화합물을 촉매로 이용하면, 경제적인 산화제인 하이포아염소산 리륨을 사용하여 좋은 입체선택성(% ee)을 얻을 수 있다.According to the present invention, an epoxy compound having high stereoselectivity can be synthesized by using the compound of Formula 1 as a catalyst for the stereoselective epoxidation reaction. Chiral epoxy compounds made in accordance with the present invention can be used as intermediates useful in the synthesis of pharmaceuticals. For example, the high stereoselectivity of indene oxide, which can be used in antiviral therapies, is considered to be much more advanced than previously reported results. Epoxychromene derivatives, a key intermediate of hypertension therapeutics, also have excellent stereoselectivity. Indicates. In addition, when the compound of Formula 1 according to the present invention is used as a catalyst, good stereoselectivity (% ee) can be obtained by using an economical oxidizing agent lithium hypochlorite.

Claims (3)

하기 화학식 1 로 표시되는 화합물;A compound represented by Formula 1; [화학식 1][Formula 1] [식 중, R1은 페닐기이거나, 둘이 서로 연결되어 6 환 고리임을 나타내고,[Wherein, R 1 is a phenyl group, or two are connected to each other to represent a 6-ring ring, R2, R3는 탄소수 1∼10 의 알킬기를 나타내고,R <2> , R <3> represents a C1-C10 alkyl group, R4는 C1∼C10의 알킬기 또는 페닐기를 나타내며,R 4 represents a C 1 to C 10 alkyl group or a phenyl group, X 는 할로겐을 나타냄]X represents halogen] 화학식 1 의 화합물을 촉매로 사용하여 화학식 2 의 올레핀 화합물을 비대칭 산화반응시켜 대응하는 비대칭 에폭사이드 화합물을 얻는 것을 특징으로 하는 비대칭 에폭사이드 화합물의 제조방법;A method for preparing an asymmetric epoxide compound, characterized by obtaining an asymmetric epoxide compound by asymmetric oxidation of the olefin compound of formula 2 using the compound of formula 1 as a catalyst; [화학식 1][Formula 1] [식 중, R1은 페닐기이거나, 둘이 서로 연결되어 6 환 고리임을 나타내고,[Wherein, R 1 is a phenyl group, or two are connected to each other to represent a 6-ring ring, R2, R3는 탄소수 1∼10 의 알킬기를 나타내고,R <2> , R <3> represents a C1-C10 alkyl group, R4는 C1∼C10의 알킬기 또는 페닐기를 나타내며,R 4 represents a C 1 to C 10 alkyl group or a phenyl group, X 는 할로겐을 나타냄]X represents halogen] [화학식 2][Formula 2] [식 중, R5는 페닐 또는 치환된 페닐기이고,[Wherein R 5 is a phenyl or substituted phenyl group, R6는 수소, C1- C3알킬 또는 -COOR7(R7은 C1∼C10알킬 또는 페닐)을 나타내고,R 6 represents hydrogen, C 1 -C 3 alkyl or —COOR 7 (R 7 is C 1 -C 10 alkyl or phenyl), 또한, R5와 R6는 페닐과 함께 고리를 형성하여In addition, R 5 and R 6 together with phenyl form a ring 와 같은 구조를 가짐을 나타내며, Has the same structure as Y 는 수소, -CN,또는-COOR7을 나타냄]Y represents hydrogen, -CN, or -COOR 7 ] 제 2 항에 있어서 산화제로 LiOCl 를 사용하여 반응을 진행시키는 것을 특징으로 하는 제조방법.The process according to claim 2, wherein the reaction is carried out using LiOCl as the oxidizing agent.
KR1020010021504A 2001-04-20 2001-04-20 Novel manganese-chiral compounds and methods of use thereof Expired - Fee Related KR100681326B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020010021504A KR100681326B1 (en) 2001-04-20 2001-04-20 Novel manganese-chiral compounds and methods of use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020010021504A KR100681326B1 (en) 2001-04-20 2001-04-20 Novel manganese-chiral compounds and methods of use thereof

Publications (2)

Publication Number Publication Date
KR20020082301A true KR20020082301A (en) 2002-10-31
KR100681326B1 KR100681326B1 (en) 2007-02-15

Family

ID=27702014

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020010021504A Expired - Fee Related KR100681326B1 (en) 2001-04-20 2001-04-20 Novel manganese-chiral compounds and methods of use thereof

Country Status (1)

Country Link
KR (1) KR100681326B1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637739A (en) * 1990-03-21 1997-06-10 Research Corporation Technologies, Inc. Chiral catalysts and catalytic epoxidation catalyzed thereby
US5403834A (en) * 1992-12-07 1995-04-04 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
UA48945C2 (en) * 1994-02-04 2002-09-16 Смітклайн Бічам Плс Process for epoxidising of prochiral olefin, catalyst for this process and method for production of catalyst
US5665890A (en) * 1995-03-14 1997-09-09 President And Fellows Of Harvard College Stereoselective ring opening reactions
JPH09286854A (en) * 1996-04-19 1997-11-04 Sumitomo Chem Co Ltd Oxidative polymerization of phenol

Also Published As

Publication number Publication date
KR100681326B1 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
US5665890A (en) Stereoselective ring opening reactions
US6448414B1 (en) Hydrolytic kinetic resolution of cyclic substrates
EP1849778B1 (en) Process for producing optically active epoxy compound, complex for use in the process, and process for producing the same
US6130340A (en) Asymmetric cycloaddition reactions
JP2003340287A (en) Chiral catalyst, catalytic oxidation, and disproportionation reaction, and production of epoxychroman and taxol
Ginotra et al. Studies on enantioselective allylic oxidation of olefins using peresters catalyzed by Cu (I)-complexes of chiral pybox ligands
CN114082446B (en) Chiral zirconium catalyst for preparing chiral α-hydroxy-β-keto acid ester compound and preparation method thereof
KR100681326B1 (en) Novel manganese-chiral compounds and methods of use thereof
CN113980028A (en) Preparation method of chiral spiro indolone compound
JP5544596B2 (en) Process for producing optically active cyclic ether compound and catalyst used therefor
KR100377712B1 (en) Asymmetrical hydrogenation of ketoisophorone derivatives
JP4605321B2 (en) Optically active oxazoline compound and method for producing optically active allyl alcohol derivative using the compound
Jin et al. Enantioselective addition of diethylzinc to aldehydes with easily prepared chiral thiazolidine catalysts
JP3921696B2 (en) Asymmetric epoxidation of cycloalkadienes
US6787657B2 (en) Optically active epoxypropionate derivative, intermediate thereof and processes for their production
KR100364010B1 (en) the New Manganese-chiral Compound and the Method for Using the Above-Compound as Catalyst in Enantioselective Epoxidation of Olefins
KR890002552B1 (en) Process for preparing alkoxy nitrobenzene
KR20020087270A (en) Asymmetric Transfer Hydrogenation of Aromatic Ketones
JP2007238547A (en) Method for producing optically active quaternary carbon-containing compound
KR20040033342A (en) Macrocyclic compounds containing isoxazoline ring and fluorine and method for preparing same
WO2006032780A1 (en) Macrocyclic chiral complexes useful as catalysts

Legal Events

Date Code Title Description
R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

Fee payment year number: 1

St.27 status event code: A-2-2-U10-U11-oth-PR1002

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

Fee payment year number: 4

St.27 status event code: A-4-4-U10-U11-oth-PR1001

PR1001 Payment of annual fee

Fee payment year number: 5

St.27 status event code: A-4-4-U10-U11-oth-PR1001

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

St.27 status event code: A-5-5-R10-R13-asn-PN2301

PR1001 Payment of annual fee

Fee payment year number: 6

St.27 status event code: A-4-4-U10-U11-oth-PR1001

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

FPAY Annual fee payment

Payment date: 20130104

Year of fee payment: 7

PR1001 Payment of annual fee

Fee payment year number: 7

St.27 status event code: A-4-4-U10-U11-oth-PR1001

FPAY Annual fee payment

Payment date: 20140124

Year of fee payment: 8

PR1001 Payment of annual fee

Fee payment year number: 8

St.27 status event code: A-4-4-U10-U11-oth-PR1001

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

Not in force date: 20150206

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

St.27 status event code: A-4-4-U10-U13-oth-PC1903

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

St.27 status event code: A-5-5-R10-R13-asn-PN2301

PC1903 Unpaid annual fee

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20150206

St.27 status event code: N-4-6-H10-H13-oth-PC1903

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

St.27 status event code: A-5-5-R10-R13-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-5-5-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000